A Study of Pembrolizumab With Trastuzumab and Chemotherapy in People With Esophagogastric Cancer
Clinical trial NCT06123338 · RECRUITING
Trial details
- NCT number
- NCT06123338
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-01
- Primary completion
- 2027-11-30
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.